SID.ir New Version

Paper Information

Journal:   CELL JOURNAL (YAKHTEH)   WINTER 2011 , Volume 12 , Number SUPPLEMENT 1 (THE 1ST INTERNATIONAL STUDENT CONGRESS ON CELL AND MOLECULAR MEDICINE); Page(s) 76 To 77.
 
Paper: 

Immunology And Immunotherapy: P-82: Assessment Of Some Critical Clinicopathological Factors And Kras Polymorphism In Colorectal Carcinoma Patients

 
 
Author(s):  Lari S.*, Ghafarzadegan K., Afsharnezhad S., Saraf Yazdi M., Pazouoki N., Hosseinkhani S.
 
* DEPARTMENT OF BIOLOGY, SCIENCE AND RESEARCH BRANCH, MASHHAD ISLAMIC AZAD UNIVERSITY, MASHHAD, IRAN
 
Abstract: 
Objective: Colorectal cancer is one of the most common forms of cancer in the world. AmongSeveral genetic events that have been documented in colorectal tumour progression, K-ras has high diagnostic value .studies have shown that K-ras mutations are found in 20-50% 0f all colon cancer mostly in codons 12 and 13, and less frequently in codon 61.The aim of this study is to identify K-ras gene mutations in codon 13 in Iranian CRC patients and to assess whether they are linked with the clinicopathological parameters.Materials and Methods: Tumor samples were collected from a consecutive series of 54 patients undergoing resective surgery for CRC. DNA was extracted from tumour. We applied RFLP-PCR for codon 13 mutation detection.Results: Colorectal patients, 18.5%, presented with mutations in codon 13 of K-ras. In our study K-ras mutations were significantly associated with CRC stage and age (p>0.05). No significant correlations were found between the mutations and sex, grade and tumor location.Conclusion: According to significant correlation between age and tumor stage with mutation in codon 13 of K-ras, we expect younger patients with colon cancer and lower response rate to treatment and higher stage in our country.
 
Keyword(s): COLORECTAL CANCER, STAGE, K-RAS, RFLPPCR
 
 
International related papers: 
 
Most related Highly related Moderately related Least related
 
References: 
  • Not Registered.
  •  
  •  
 
Citations: 
  • Not Registered.
 
+ Click to Cite.
APA: Copy

LARI, S., & GHAFARZADEGAN, K., & AFSHARNEZHAD, S., & SARAF YAZDI, M., & PAZOUOKI, N., & HOSSEINKHANI, S. (2011). IMMUNOLOGY AND IMMUNOTHERAPY: P-82: ASSESSMENT OF SOME CRITICAL CLINICOPATHOLOGICAL FACTORS AND KRAS POLYMORPHISM IN COLORECTAL CARCINOMA PATIENTS. CELL JOURNAL (YAKHTEH), 12(SUPPLEMENT 1 (THE 1ST INTERNATIONAL STUDENT CONGRESS ON CELL AND MOLECULAR MEDICINE)), 76-77. https://www.sid.ir/en/journal/ViewPaper.aspx?id=188738



Vancouver: Copy

LARI S., GHAFARZADEGAN K., AFSHARNEZHAD S., SARAF YAZDI M., PAZOUOKI N., HOSSEINKHANI S.. IMMUNOLOGY AND IMMUNOTHERAPY: P-82: ASSESSMENT OF SOME CRITICAL CLINICOPATHOLOGICAL FACTORS AND KRAS POLYMORPHISM IN COLORECTAL CARCINOMA PATIENTS. CELL JOURNAL (YAKHTEH). 2011 [cited 2022August18];12(SUPPLEMENT 1 (THE 1ST INTERNATIONAL STUDENT CONGRESS ON CELL AND MOLECULAR MEDICINE)):76-77. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=188738



IEEE: Copy

LARI, S., GHAFARZADEGAN, K., AFSHARNEZHAD, S., SARAF YAZDI, M., PAZOUOKI, N., HOSSEINKHANI, S., 2011. IMMUNOLOGY AND IMMUNOTHERAPY: P-82: ASSESSMENT OF SOME CRITICAL CLINICOPATHOLOGICAL FACTORS AND KRAS POLYMORPHISM IN COLORECTAL CARCINOMA PATIENTS. CELL JOURNAL (YAKHTEH), [online] 12(SUPPLEMENT 1 (THE 1ST INTERNATIONAL STUDENT CONGRESS ON CELL AND MOLECULAR MEDICINE)), pp.76-77. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=188738.



 
 
Yearly Visit 30
 
 
Latest on Blog
Enter SID Blog